2
Announcements
Trials
Browse
Landscape
Status
Completed
5
Terminated
3
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
437
Neoplasms
322
Carcinoma, Non-Small-Cell Lung
250
Prostatic Neoplasms
240
Lung Neoplasms
174
Colorectal Neoplasms
156
Pancreatic Neoplasms
148
Neoplasm Metastasis
142
Leukemia, Myeloid, Acute
140
Multiple Myeloma
130
Lymphoma
127
Carcinoma, Hepatocellular
127
Ovarian Neoplasms
109
Melanoma
109
Brain Neoplasms
101
Recurrence
100
Head and Neck Neoplasms
100
Leukemia, Lymphocytic, Chronic, B-Cell
96
Leukemia
96
Precursor Cell Lymphoblastic Leukemia-Lymphoma
90
Glioblastoma
85
Lymphoma, Non-Hodgkin
83
Colonic Neoplasms
79
Squamous Cell Carcinoma of Head and Neck
76
Lymphoma, Follicular
76
Carcinoma, Renal Cell
74
Lymphoma, Large B-Cell, Diffuse
71
Hematologic Neoplasms
69
Sarcoma
60
Stomach Neoplasms
58
Interventions
Glucose Tolerance Test
1
Continuous Glucose Monitoring
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Iron Overload
×
Clear all
NCT03141398
2017-07-26
CGMs
Hamad Medical Corporation
Withdrawn